Athenex, Inc. 3 SEC Filings

Filed On	Filing
24 Feb 2022	Form 3: Annoni Joe, Chief Financial Officer No securities owned
10 Jan 2022	Form 3: Cook Timothy DeVere, See Remarks
01 Dec 2021	Form 3: Lang Daniel, Pres Cell Therapy, VP Corp Dev Holds 73,413 shares of Common Stock
27 Oct 2021	Form 3: Smolinski Michael, Chief Scientific Officer Holds 5,173 shares of Common Stock
17 Aug 2021	Form 3: Adams Steven J., Interim Chief Acct Officer
12 Aug 2020	Form 3: Spiegel Robert J., Director No securities owned
23 Jun 2020	Form 3: Bair Teresa Brophy, General Counsel, SVP Admin.
08 May 2019	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 9,096,022 shares of Common Stock
02 Apr 2019	Form 3: Koh John, Director No securities owned
01 Apr 2019	Form 3: Kanfer Jordan, Director Holds 1,684 shares of Common Stock
01 Apr 2019	Form 3: Vierling John, Director No securities owned
01 Apr 2019	Form 3: Davis Stephanie A, Director No securities owned
23 Aug 2018	Form 3: Sze Randoll, Chief Financial Officer
02 Jul 2018	Form 3: Tsang Benson Kwan Hung, Director No securities owned
09 Jan 2018	Form 3: Shen Li, See Remarks. Holds 200 shares of Common Stock
13 Jul 2017	Form 3: Ma Huateng, 10% owner and 1 other Holds 6,444,032 shares of Common Stock
13 Jun 2017	Form 3: Fok Manson, Director Holds 1,242,336 shares of Common Stock
13 Jun 2017	Form 3: Campbell Kim, Director
13 Jun 2017	Form 3: Riehle J Nick, Chief Financial Officer No securities owned
13 Jun 2017	Form 3: Zukin James, Director Holds 465,100 shares of Common Stock

Comments